Autolus Therapeutics (AUTL) Other Non-Current Assets (2018 - 2026)
Autolus Therapeutics' (AUTL) quarterly Other Non-Current Assets came in at $1.0 million in Q4 2025, up 7.17% YoY from $963000.0 in Q4 2024, and little changed on a QoQ basis from $1.0 million in Q3 2025.
Autolus Therapeutics (AUTL) Other Non-Current Assets (2018 - 2026) Analysis & Trends
Autolus Therapeutics (AUTL) has 8 years of Other Non-Current Assets data on file, last reported at $1.0 million in Q4 2025.
- Quarterly Other Non-Current Assets rose 7.17% year-over-year to $1.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.0 million (up 7.17% YoY) and the FY2025 annual result came in at $1.0 million, up 7.17% from the prior year.
- Other Non-Current Assets was little changed at $1.0 million in Q4 2025, from $1.0 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $5.3 million in Q2 2025 to a low of $943000.0 in Q3 2023.
- A 5-year average of $1.7 million and a median of $1.8 million in 2021 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2023 — Other Non-Current Assets tumbled 54.83% — and 2025, when it soared 438.18%.
- Tracing AUTL's Other Non-Current Assets over 5 years: stood at $2.4 million in 2021, then fell by 7.87% to $2.2 million in 2022, then sank by 54.83% to $983000.0 in 2023, then declined by 2.03% to $963000.0 in 2024, then gained by 7.17% to $1.0 million in 2025.
- The last three Other Non-Current Assets figures came in at $1.0 million (Q4 2025), $1.0 million (Q3 2025), and $5.3 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 124.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 42.45 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 109.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 18,237.65 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 62.96 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 65.13 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 104.44 Mn |
| 10 | Autolus Therapeutics | 763.37 Mn | 561.74 Mn | 25.22 Mn | 1.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.02 Mn |
| Dec 31, 2025 | 1.03 Mn |
| Sep 30, 2025 | 1.03 Mn |
| Jun 30, 2025 | 5.26 Mn |
| Mar 31, 2025 | 993,000.00 |
| Dec 31, 2024 | 963,000.00 |
| Sep 30, 2024 | 1.03 Mn |
| Jun 30, 2024 | 977,000.00 |
| Mar 31, 2024 | 975,000.00 |
| Dec 31, 2023 | 983,000.00 |
| Sep 30, 2023 | 943,000.00 |
| Jun 30, 2023 | 1.86 Mn |
| Mar 31, 2023 | 1.82 Mn |
| Dec 31, 2022 | 2.18 Mn |
| Sep 30, 2022 | 1.72 Mn |
| Jun 30, 2022 | 1.89 Mn |
| Mar 31, 2022 | 2.12 Mn |
| Dec 31, 2021 | 2.36 Mn |
| Sep 30, 2021 | 1.80 Mn |
| Jun 30, 2021 | 1.85 Mn |